• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • DPX-COVID-19 has potential to improve duration of immune response expresspharma
    October 21, 2020
    On October 8, Canada-based biotech company, IMV, which is soon to publish pre-clinical data on DPX-COVID-19, its immunotherapy-based vaccine candidate for the prevention of SARS-COV-2, announced that to increase its current manufacturing capacity ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service